<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Hormonal Agents &amp; Tyrosine Kinase Inhibitors</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`üß† Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Hormonal Agents &amp; Tyrosine Kinase Inhibitors</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                14 Questions | 14 Total Marks | 24 min Duration | ~102.86 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 14 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 24 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 14</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Hormonal Agents &amp; Tyrosine Kinase Inhibitors - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 14</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 14 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "Among the following, glucarpidase is used in which condition?", "options": [{"label": "A", "text": "Radiation recall syndrome", "correct": false}, {"label": "B", "text": "Treatment of toxic plasma methotrexate concentrations", "correct": true}, {"label": "C", "text": "To counteract the activity of asparaginase", "correct": false}, {"label": "D", "text": "To prevent cardiotoxicity induced by dactinomycin", "correct": false}], "correct_answer": "B. Treatment of toxic plasma methotrexate concentrations", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Treatment of toxic plasma methotrexate concentrations Glucarpidase is a carboxypeptidase enzyme indicated for the treatment of toxic plasma methotrexate concentrations (>1 micromole per liter) in patients with delayed methotrexate clearance due to impaired renal function.</p>\n<p><strong>Highyeild:</strong></p><p>Glucarpidase: carboxypeptidase enzyme used for the treatment of toxic plasma methotrexate concentrations (>1 micromole per liter) in patients with delayed methotrexate clearance due to impaired renal function converts methotrexate to its inactive metabolite IV drug provides an alternate non-renal pathway for methotrexate elimination in patients with renal dysfunction Leucovorin is a substrate for Glucarpidase, so do not administer leucovorin within 2 hours before or after a dose of glucarpidase</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. RADIATION RECALL SYNDROME, Radiation recall syndrome (a severe skin reaction that occurs when certain chemotherapy drugs are administered during or soon after radiation treatment) has been reported by people with breast cancer, hypothyroidism, and Wilms tumor. Option: C. Neutralizing antibodies and asparaginase inactivation may occur without clinical manifestations of hypersensitivity, also called ‚Äú silent inactivation,‚Äù which seems to be uncommon at a rate of less than 10% Option: D.Dexrazoxane has been used to protect the heart against the cardiotoxic side effects of chemotherapeutic drugs such as anthracyclines, such as daunorubicin or doxorubicin, or other chemotherapeutic agents.</p>\n<p><strong>Table:</strong></p><p>Methotrexate (Class: Antineoplastic/antimetabolite; antipsoriatic; antiarthritic) Action Competitively\n      inhibits dihydrofolic acid reductase and thereby inhibits DNA synthesis\n      and cellular replication. In\n      rheumatoid arthritis, believed to reduce immune function Indications Treatment\n      and prophylaxis of acute meningeal lymphocytic leukemia; treatment of\n      breast cancer, epidermoid cancers of head and neck, advanced mycosis\n      symptomatic control of severe psoriasis and severe rheumatoid arthritis. Unlabeled\n      use(s): Reduction of corticosteroid requirements in patients with severe\n      corticosteroid-dependent asthma, believed to reduce immune function t¬Ω 6-9hrs,\n     increase with hydroxychloroquine. Excreted in urine (70%), Bile (30%) Contraindications Use in\n      nursing mothers. in\n      pregnancy, alcoholism,\n      alcoholic liver disease, chronic liver disease, overt or\n      laboratory evidence of immunodeficiency syndrome and preexisting\n      blood dyscrasias (eg, leukopenia, thrombocytopenia). Adverse\n     Effects: Nausea\n      and mucosal ulcer. Hepatoxicity. \"hypersensibility\"\n      reaction to the Lung.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is not a mechanism for Methotrexate resistance?", "options": [{"label": "A", "text": "Altered forms of DHFR", "correct": false}, {"label": "B", "text": "Increased concentrations of intracellular DHFR", "correct": false}, {"label": "C", "text": "Increased ability to synthesize methotrexate polyglutamate", "correct": true}, {"label": "D", "text": "Increased expression of a drug efflux transporter", "correct": false}], "correct_answer": "C. Increased ability to synthesize methotrexate polyglutamate", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Increased ability to synthesize methotrexate polyglutamate It is a mechanism by which MTX produces long-term action, not resistance</p>\n<p><strong>Highyeild:</strong></p><p>Mechanisms for Methotrexate resistance are Impaired transport of methotrexate into cells Production of altered forms of DHFR that have decreased affinity for the inhibitor Increased concentrations of intracellular DHFR through gene amplification or altered gene regulation Decreased ability to synthesize methotrexate polyglutamate Increased expression of a drug efflux transporter of the MRP class</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option A. Dihydrofolate reductase, or DHFR, is an enzyme that reduces dihydrofolic acid to tetrahydrofolic acid , using NADPH as an electron donor, which can be converted to the kinds of tetrahydrofolate cofactors used in 1-carbon transfer. Option C. Methotrexate and its long-acting polyglutamate metabolites also exert anti-inflammatory effects by releasing the endogenous autocoid adenosine. 3 As potent inhibitors of the enzyme 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase. Option: D. Efflux is the moving of a variety of different compounds out of cells, such as antibiotics, heavy metals, organic pollutants, plant-produced compounds, quorum sensing signals, bacterial metabolites, and neurotransmitters. All microorganisms, with a few exceptions, have highly conserved DNA sequences in their genome that encode efflux pumps. Efflux pumps actively move substances out of a microorganism, in a process known as active efflux.</p>\n<p><strong>Table:</strong></p><p>Treating\n  with Methotrexate Indications Contraindications Hemodynamically\n  stable patient Breastfeeding Desires\n  future fertility Immunodeficiency Able\n  to return for follow up care Renal,\n  Liver, or Pulmonary disease General\n  anesthesia poses a risk Abnormal\n  creatinine and AST No\n  contraindications to methotrexate Peptic\n  Ulcer Disease Unruptured\n  mass < 3.5 cm Blood\n  disorders *No\n  fetal cardiac activity Known\n  sensitivity to methotrexate *hCG\n  level preferably < 15,000 *Gestational\n  sac > 3.5 cm *Cardiac\n  activity -Teal\n  and Mukul</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following statement is false about Fulvestrant?", "options": [{"label": "A", "text": "It is a selective estrogen receptor down regulator (SERD)", "correct": false}, {"label": "B", "text": "better safety and faster onset of action than Tamoxifen", "correct": false}, {"label": "C", "text": "short duration of action than tamoxifen", "correct": true}, {"label": "D", "text": "Indicated for tamoxifen-resistant breast cancer", "correct": false}], "correct_answer": "C. short duration of action than tamoxifen", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>short duration of action than tamoxifen Fulvestrant has better safety, faster action, and longer duration of action than tamoxifen</p>\n<p><strong>Highyeild:</strong></p><p>Fulvestrant It is the first member of a distinct class of ER ligands called ‚Äòselective estrogen receptor down-regulators‚Äô (SERDs) or ‚Äòpure estrogen antagonists‚Äô that has been introduced for the treatment of locally advanced or metastatic ER-positive breast cancer in postmenopausal women which has stopped responding to tamoxifen. In contrast to tamoxifen, it inhibits ER dimerization so that ER interaction with DNA is prevented and receptor degradation is enhanced. The ER is thus downregulated resulting in more complete suppression of ER-responsive gene function. This feature along with its higher affinity for the ER probably accounts for its efficacy in tamoxifen-resistant cases.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A- selective estrogen receptor degrader or down regulator (SERD ) is a type of drug that binds to the estrogen receptor (ER) and, in the process of doing so, causes the ER to be degraded and thus downregulated. They are used to treat estrogen receptor-sensitive or progesterone receptor-sensitive breast cancer Option: B- Tamoxifen is a medicine used in the treatment of breast cancer in both men and women. It is also used to reduce the risk of breast cancer in women with a high chance of developing it. This medicine helps to slow down the growth and multiplication of cancer cells. Option:D- Fulvestrant continues to demonstrate clinical benefits in real-world settings and appears to be well tolerated as first-line for the treatment of postmenopausal women with ER-positive ABC . Breast cancer (BC) is the most frequent type of carcinoma and the leading cause of cancer-related mortality in women</p>\n<p><strong>Table:</strong></p><p>Classification\nof anticancer agents Hormonal\ndrugs 1. Glucocorticods: Prednisolone 2. Estrogens: Fosfestrol, ethinylestradiol 3. Selective estrogen receptor modulators:\nTamoxifen 4. Selective estrogen receptor down-regulators:\nFulvestrant 5. Aromatase inhibitors: Letrozole, Anastrozole 6. Antiandrogen: Flutamide 7. 5-a reductase inhibitor: Finasteride 8.\nGnRH analogues: Nafarelin, Triotorelin</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 12-year-old girl visits her physician for follow-up after treatment with methotrexate for acute lymphoblastic leukemia. Stool analysis reveals blood in the stool. Her platelet count is very low. Which of these substances should be administered immediately?", "options": [{"label": "A", "text": "Vitamin K", "correct": false}, {"label": "B", "text": "Leucovorin", "correct": true}, {"label": "C", "text": "Deferoxamine", "correct": false}, {"label": "D", "text": "Penicillamine", "correct": false}], "correct_answer": "B. Leucovorin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Leucovorin This patient is having methotrexate toxicity presenting with decreased platelet count (reveals blood in stool) The antidote for this is Leucovorin</p>\n<p><strong>Highyeild:</strong></p><p>Folinic acid (Leucovorin = citrovorum factor = 5-formyl-THFA) it is an active coenzyme form it does not need to be reduced by DHFRase before it can act. Since Methotrexate is a DHFRase inhibitor, folic acid is not useful so its toxicity is not counteracted by folic acid Methotrexate toxicity is treated d by folinic acid I.V</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A- used for warfari n toxicity. Option: C- used for iron toxicity. Option: D- Used for copper toxicity</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Initial Flaring up of symptoms in prostatic carcinoma is shown by which of the following drugs?", "options": [{"label": "A", "text": "Goserelin", "correct": false}, {"label": "B", "text": "Nafarelin", "correct": false}, {"label": "C", "text": "Leuprolide", "correct": false}, {"label": "D", "text": "all of the above", "correct": true}], "correct_answer": "D. all of the above", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>all of the above</p>\n<p><strong>Highyeild:</strong></p><p>Gonadotropin Releasing Hormone Agonists are Goserelin,Nafarelin and leuprolide Continuous administration of Gonadotropin-Releasing Hormone Agonists leads to the transient release of LH and FSH this will lead to the flaring up of symptoms in prostatic carcinoma and then inhibition of the release of Gonadotropins these are used in the treatment of advanced prostatic carcinoma GnRH Antagonists are Cetrorelix, Ganirelix, degarelix, and abarelix and these are antagonists and don‚Äôt show initial Flaring up of symptoms in prostatic carcinoma</p>\n<p><strong>Random:</strong></p><p>Explanation for all options: - Option: A. Goserelin is a medication that is used to suppress production of the sex hormones (testosterone and estrogen), particularly in the treatment of breast and prostate cancer. It is an injectable gonadotropin-releasing hormone agonist (GnRH agonist). Option: B. Nafarelin is a medication that is used to suppress production of the sex hormones (testosterone and estrogen), particularly in the treatment of breast and prostate cancer. It is an injectable gonadotropin-releasing hormone agonist (GnRH agonist). Option : C. Leuprolide is used in the treatment of prostate cancer. It is also used to treat endometriosis (endometrium of the uterus grows excessively and causes symptoms like pain, heavy or irregular periods), uterine fibroids, and central precocious puberty</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following drug is a combination of IL-2 with diphtheria toxin and used for cutaneous T-cell lymphoma?", "options": [{"label": "A", "text": "Aldesleukin", "correct": false}, {"label": "B", "text": "Denileukin diftitox", "correct": true}, {"label": "C", "text": "Idelalisib", "correct": false}, {"label": "D", "text": "Ipilimumab", "correct": false}], "correct_answer": "B. Denileukin diftitox", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Denileukin diftitox Antineoplastic agent, an engineered protein combining interleukin-2 and diphtheria toxin. Denileukin diftitox could bind to interleukin-2 receptors and introduce the diphtheria toxin into cells that express those receptors.</p>\n<p><strong>Highyeild:</strong></p><p>Denileukin Diftitox The name itself is telling ‚Äòleukin‚Äô i.e IL-2 ‚Äòdeftitox‚Äô i.e defti...diphtheria, tox...toxin Aldesleukin is recombinant IL-2 for RCC and malignant myeloma Idelalisib is a PI3 kinase inhibitor Ipilimumab is a CTLA-4 inhibitor Denileukin diftitox is an immunotoxin made from the genetic recombination of IL-2 and the catalytically active fragment of diphtheria toxin. The high-affinity IL-2R has limited tissue expression and is an attractive target for an immunotoxin. Introduction of the diphtheria toxin fragment into cells leads to ADP-ribosylation and inactivation of eukaryotic elongation factor EF-2, inhibition of protein synthesis, and thence cell death.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A -Aldesleukin Interleukin-2 (IL-2 ) is an interleukin, a type of cytokine signaling molecule in the immune system. It is a 15.5‚Äì16 kDa protein that regulates the activities of white blood cells (leukocytes, often lymphocytes) that are responsible for immunity. IL-2 is part of the body